Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial
Hodi, F Stephen, Dr, Chesney, Jason, Prof, Pavlick, Anna C, MD, Robert, Caroline, Prof, Grossmann, Kenneth F, MD, McDermott, David F, MD, Linette, Gerald P, MD, Meyer, Nicolas, Prof, Giguere, Jeffrey K, MD, Agarwala, Sanjiv S, Prof, Shaheen, Montaser, MD, Ernstoff, Marc S, Prof, Minor, David R, MD, Salama, April K, MD, Taylor, Matthew H, MD, Ott, Patrick A, MD, Horak, Christine, PhD, Gagnier, Paul, MD, Jiang, Joel, PhD, Wolchok, Jedd D, Prof, Postow, Michael A, MD
Published in The lancet oncology (01.11.2016)
Published in The lancet oncology (01.11.2016)
Get full text
Journal Article